{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["ADMET", "African natural products", "SARS- papain-like protease", "docking", "molecular dynamics simulations", "molecular fingerprints", "structural similarity", "toxicity"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36422263", "DateRevised": {"Year": "2022", "Month": "11", "Day": "28"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "11", "Day": "16"}], "Language": ["eng"], "ELocationID": ["1122", "10.3390/metabo12111122"], "Journal": {"ISSN": "2218-1989", "JournalIssue": {"Volume": "12", "Issue": "11", "PubDate": {"Year": "2022", "Month": "Nov", "Day": "16"}}, "Title": "Metabolites", "ISOAbbreviation": "Metabolites"}, "ArticleTitle": "The Discovery of Potential SARS-CoV-2 Natural Inhibitors among 4924 African Metabolites Targeting the Papain-like Protease: A Multi-Phase In Silico Approach.", "Abstract": {"AbstractText": ["Four compounds, hippacine, 4,2'-dihydroxy-4'-methoxychalcone, 2',5'-dihydroxy-4-methoxychalcone, and wighteone, were selected from 4924 African natural metabolites as potential inhibitors against SARS-CoV-2 papain-like protease (PLpro, PDB ID: 3E9S). A multi-phased in silico approach was employed to select the most similar metabolites to the co-crystallized ligand (<b>TTT</b>) of the PLpro through molecular fingerprints and structural similarity studies. Followingly, to examine the binding of the selected metabolites with the PLpro (molecular docking. Further, to confirm this binding through molecular dynamics simulations. Finally, in silico ADMET and toxicity studies were carried out to prefer the most convenient compounds and their drug-likeness. The obtained results could be a weapon in the battle against COVID-19 via more in vitro and in vivo studies."]}, "AuthorList": [{"Identifier": ["0000-0002-2546-8035"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, College of Pharmacy, AlMaarefa University, Riyadh 13713, Saudi Arabia."}], "LastName": "Elkaeed", "ForeName": "Eslam B", "Initials": "EB"}, {"Identifier": ["0000-0002-8146-993X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt."}], "LastName": "Khalifa", "ForeName": "Mohamed M", "Initials": "MM"}, {"Identifier": ["0000-0001-6489-6035"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia."}], "LastName": "Alsfouk", "ForeName": "Bshra A", "Initials": "BA"}, {"Identifier": ["0000-0003-4497-5013"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia."}], "LastName": "Alsfouk", "ForeName": "Aisha A", "Initials": "AA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Al-Azhar University, Nasr City, Cairo 11884, Egypt."}], "LastName": "El-Attar", "ForeName": "Abdul-Aziz M M", "Initials": "AMM"}, {"Identifier": ["0000-0002-6955-2263"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt."}], "LastName": "Eissa", "ForeName": "Ibrahim H", "Initials": "IH"}, {"Identifier": ["0000-0001-8566-1980"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacognosy and Medicinal Plants Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt."}, {"Identifier": [], "Affiliation": "Biopharmaceutical Products Research Department, Genetic Engineering and Biotechnology Research Institute, City of Scientific Research and Technological Applications (SRTA-City), Alexandria 21934, Egypt."}], "LastName": "Metwaly", "ForeName": "Ahmed M", "Initials": "AM"}], "GrantList": [{"GrantID": "PNURSP2022R142", "Agency": "Princess Nourah bint Abdulrahman University", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Metabolites", "NlmUniqueID": "101578790", "ISSNLinking": "2218-1989"}, "CoiStatement": "No conflict of interest regarding this paper to be declared."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "WHO  WHO Coronavirus (COVID-19) Dashboard.  [(accessed on 12 November 2022)].  Available online:  https://covid19.who.int/"}, {"Citation": "Engel T. Basic overview of chemoinformatics. J. Chem. Inf. Model. 2006;46:2267\u20132277. doi: 10.1021/ci600234z.", "ArticleIdList": ["10.1021/ci600234z", "17125169"]}, {"Citation": "Xu J., Hagler A. Chemoinformatics and drug discovery. Molecules. 2002;7:566\u2013600. doi: 10.3390/70800566.", "ArticleIdList": ["10.3390/70800566"]}, {"Citation": "Marrone T.J., Briggs A., James M., McCammon J.A. Structure-based drug design: Computational advances. Annu. Rev. Pharmacol. Toxicol. 1997;37:71\u201390. doi: 10.1146/annurev.pharmtox.37.1.71.", "ArticleIdList": ["10.1146/annurev.pharmtox.37.1.71", "9131247"]}, {"Citation": "Li N., Wang Y., Li W., Li H., Yang L., Wang J., Mahdy H.A., Mehany A., Jaiash D.A., Santali E.Y. Screening of Some Sulfonamide and Sulfonylurea Derivatives as Anti-Alzheimer\u2019s Agents Targeting BACE1 and PPAR\u03b3. J. Chem. 2020;2020:1631243. doi: 10.1155/2020/1631243.", "ArticleIdList": ["10.1155/2020/1631243"]}, {"Citation": "Abdel-Aziz H.A., Eldehna W.M., Fares M., Al-Rashood S.T., Al-Rashood K.A., Abdel-Aziz M.M., Soliman D.H. Synthesis, biological evaluation and 2D-QSAR study of halophenyl bis-hydrazones as antimicrobial and antitubercular agents. Int. J. Mol. Sci. 2015;16:8719\u20138743. doi: 10.3390/ijms16048719.", "ArticleIdList": ["10.3390/ijms16048719", "PMC4425105", "25903147"]}, {"Citation": "March-Vila E., Pinzi L., Sturm N., Tinivella A., Engkvist O., Chen H., Rastelli G. On the integration of in silico drug design methods for drug repurposing. Front. Pharmacol. 2017;8:298. doi: 10.3389/fphar.2017.00298.", "ArticleIdList": ["10.3389/fphar.2017.00298", "PMC5440551", "28588497"]}, {"Citation": "Zhang W., Pei J., Lai L. Computational multitarget drug design. J. Chem. Inf. Model. 2017;57:403\u2013412. doi: 10.1021/acs.jcim.6b00491.", "ArticleIdList": ["10.1021/acs.jcim.6b00491", "28166637"]}, {"Citation": "Youssef M.I., Zhou Y., Eissa I.H., Wang Y., Zhang J., Jiang L., Hu W., Qi J., Chen Z. Tetradecyl 2,3-dihydroxybenzoate alleviates oligodendrocyte damage following chronic cerebral hypoperfusion through IGF-1 receptor. Neurochem. Int. 2020;138:104749. doi: 10.1016/j.neuint.2020.104749.", "ArticleIdList": ["10.1016/j.neuint.2020.104749", "32387468"]}, {"Citation": "Alsaif N.A., Taghour M.S., Alanazi M.M., Obaidullah A.J., Al-Mehizia A.A., Alanazi M.M., Aldawas S., Elwan A., Elkady H. Discovery of new VEGFR-2 inhibitors based on bis ([1, 2, 4] triazolo)[4,3-a:3\u2032,4\u2032-c] quinoxaline derivatives as anticancer agents and apoptosis inducers. J. Enzym. Inhib. Med. Chem. 2021;36:1093\u20131114. doi: 10.1080/14756366.2021.1915303.", "ArticleIdList": ["10.1080/14756366.2021.1915303", "PMC8168755", "34056992"]}, {"Citation": "Alsaif N.A., Dahab M.A., Alanazi M.M., Obaidullah A.J., Al-Mehizia A.A., Alanazi M.M., Aldawas S., Mahdy H.A., Elkady H. New quinoxaline derivatives as VEGFR-2 inhibitors with anticancer and apoptotic activity: Design, molecular modeling, and synthesis. Bioorg. Chem. 2021;110:104807. doi: 10.1016/j.bioorg.2021.104807.", "ArticleIdList": ["10.1016/j.bioorg.2021.104807", "33721808"]}, {"Citation": "El-Adl K., Ibrahim M.-K., Alesawy M.S., Eissa I.H. [1, 2, 4] Triazolo [4, 3-c] quinazoline and bis ([1, 2, 4] triazolo)[4,3-a:4\u2032,3\u2032-c] quinazoline derived DNA intercalators: Design, synthesis, in silico ADMET profile, molecular docking and anti-proliferative evaluation studies. Bioorg. Med. Chem. 2021;30:115958. doi: 10.1016/j.bmc.2020.115958.", "ArticleIdList": ["10.1016/j.bmc.2020.115958", "33360576"]}, {"Citation": "El-Metwally S.A., Abou-El-Regal M.M., Eissa I.H., Mehany A.B., Mahdy H.A., Elkady H., Elwan A., Elkaeed E.B. Discovery of thieno [2, 3-d] pyrimidine-based derivatives as potent VEGFR-2 kinase inhibitors and anti-cancer agents. Bioorg. Chem. 2021;112:104947. doi: 10.1016/j.bioorg.2021.104947.", "ArticleIdList": ["10.1016/j.bioorg.2021.104947", "33964580"]}, {"Citation": "Alanazi M.M., Eissa I.H., Alsaif N.A., Obaidullah A.J., Alanazi W.A., Alasmari A.F., Albassam H., Elkady H., Elwan A. Design, synthesis, docking, ADMET studies, and anticancer evaluation of new 3-methylquinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers. J. Enzym. Inhib. Med. Chem. 2021;36:1760\u20131782. doi: 10.1080/14756366.2021.1956488.", "ArticleIdList": ["10.1080/14756366.2021.1956488", "PMC8344243", "34340610"]}, {"Citation": "Alanazi M.M., Alaa E., Alsaif N.A., Obaidullah A.J., Alkahtani H.M., Al-Mehizia A.A., Alsubaie S.M., Taghour M.S., Eissa I.H. Discovery of new 3-methylquinoxalines as potential anti-cancer agents and apoptosis inducers targeting VEGFR-2: Design, synthesis, and in silico studies. J. Enzym. Inhib. Med. Chem. 2021;36:1732\u20131750. doi: 10.1080/14756366.2021.1945591.", "ArticleIdList": ["10.1080/14756366.2021.1945591", "PMC8330740", "34325596"]}, {"Citation": "Elkaeed E.B., Yousef R.G., Elkady H., Alsfouk A.A., Husein D.Z., Ibrahim I.M., Alswah M., Elzahabi H.S.A., Metwaly A.M., Eissa I.H. A New Theobromine-Based EGFRWT and EGFRT790M Inhibitor and Apoptosis Inducer: Design, Semi-Synthesis, Docking, DFT, MD Simulations, and In Vitro Studies. Processes. 2022;10:2290. doi: 10.3390/pr10112290.", "ArticleIdList": ["10.3390/pr10112290"]}, {"Citation": "Metwaly A.M., Ghoneim M.M., Eissa I.H., Elsehemy I.A., Mostafa A.E., Hegazy M.M., Afifi W.M., Dou D. Traditional ancient Egyptian medicine: A review. Saudi J. Biol. Sci. 2021;28:5823\u20135832. doi: 10.1016/j.sjbs.2021.06.044.", "ArticleIdList": ["10.1016/j.sjbs.2021.06.044", "PMC8459052", "34588897"]}, {"Citation": "Han X., Yang Y., Metwaly A.M., Xue Y., Shi Y., Dou D. The Chinese herbal formulae (Yitangkang) exerts an antidiabetic effect through the regulation of substance metabolism and energy metabolism in type 2 diabetic rats. J. Ethnopharmacol. 2019;239:111942. doi: 10.1016/j.jep.2019.111942.", "ArticleIdList": ["10.1016/j.jep.2019.111942", "31075380"]}, {"Citation": "Shin D., Mukherjee R., Grewe D., Bojkova D., Baek K., Bhattacharya A., Schulz L., Widera M., Mehdipour A.R., Tascher G., et al. Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity. Nature. 2020;587:657\u2013662. doi: 10.1038/s41586-020-2601-5.", "ArticleIdList": ["10.1038/s41586-020-2601-5", "PMC7116779", "32726803"]}, {"Citation": "B\u00e1ez-Santos Y.M., John S.E.S., Mesecar A.D. The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds. Antivir. Res. 2015;115:21\u201338. doi: 10.1016/j.antiviral.2014.12.015.", "ArticleIdList": ["10.1016/j.antiviral.2014.12.015", "PMC5896749", "25554382"]}, {"Citation": "Alesawy M.S., Abdallah A.E., Taghour M.S., Elkaeed E.B., Eissa I.H., Metwaly A.M. In Silico Studies of Some Isoflavonoids as Potential Candidates against COVID-19 Targeting Human ACE2 (hACE2) and Viral Main Protease (Mpro) Molecules. 2021;26:2806. doi: 10.3390/molecules26092806.", "ArticleIdList": ["10.3390/molecules26092806", "PMC8126168", "34068579"]}, {"Citation": "El-Demerdash A., Metwaly A.M., Hassan A., El-Aziz A., Mohamed T., Elkaeed E.B., Eissa I.H., Arafa R.K., Stockand J.D. Comprehensive virtual screening of the antiviral potentialities of marine polycyclic guanidine alkaloids against SARS-CoV-2 (COVID-19) Biomolecules. 2021;11:460. doi: 10.3390/biom11030460.", "ArticleIdList": ["10.3390/biom11030460", "PMC8003478", "33808721"]}, {"Citation": "ANPDB African Natural Products Database.  [(accessed on 11 November 2021)].  Available online:  http://african-compounds.org/anpdb/compounds_list/"}, {"Citation": "Fu Z., Huang B., Tang J., Liu S., Liu M., Ye Y., Liu Z., Xiong Y., Zhu W., Cao D. The complex structure of GRL0617 and SARS-CoV-2 PLpro reveals a hot spot for antiviral drug discovery. Nat. Commun. 2021;12:488. doi: 10.1038/s41467-020-20718-8.", "ArticleIdList": ["10.1038/s41467-020-20718-8", "PMC7817691", "33473130"]}, {"Citation": "R.P.D. Bank. X-ray Structural and Biological Evaluation of a Series of Potent and Highly Selective Inhibitors of Human Coronavirus Papain-Like Proteases.  [(accessed on 14 August 2022)].  Available online:  https://www.rcsb.org/structure/4OW0.", "ArticleIdList": ["PMC3983375", "24568342"]}, {"Citation": "Parmar D.R., Soni J.Y., Guduru R., Rayani R.H., Kusurkar R.V., Vala A.G., Talukdar S.N., Eissa I.H., Metwaly A.M., Khalil A. Discovery of new anticancer thiourea-azetidine hybrids: Design, synthesis, in vitro antiproliferative, SAR, in silico molecular docking against VEGFR-2, ADMET, toxicity, and DFT studies. Bioorg. Chem. 2021;115:105206. doi: 10.1016/j.bioorg.2021.105206.", "ArticleIdList": ["10.1016/j.bioorg.2021.105206", "34339975"]}, {"Citation": "Yousef R., Sakr H., Eissa I., Mehany A., Metwaly A., Elhendawy M.A., Radwan M., ElSohly M.A., Abulkhair H.S., El-Adl K. New quinoxaline-2 (1H)-ones as potential VEGFR-2 inhibitors: Design, synthesis, molecular docking, ADMET profile and anti-proliferative evaluations. New J. Chem. 2021;45:16949\u201316964. doi: 10.1039/D1NJ02509K.", "ArticleIdList": ["10.1039/D1NJ02509K", "34175720"]}, {"Citation": "Amer H.H., Alotaibi S.H., Trawneh A.H., Metwaly A.M., Eissa I.H. Anticancer activity, spectroscopic and molecular docking of some new synthesized sugar hydrazones, Arylidene and \u03b1-Aminophosphonate derivatives. Arab. J. Chem. 2021;14:103348. doi: 10.1016/j.arabjc.2021.103348.", "ArticleIdList": ["10.1016/j.arabjc.2021.103348"]}, {"Citation": "Alesawy M.S., Al-Karmalawy A.A., Elkaeed E.B., Alswah M., Belal A., Taghour M.S., Eissa I.H. Design and discovery of new 1,2,4-triazolo[4,3-c] quinazolines as potential DNA intercalators and topoisomerase II inhibitors. Arch. Der Pharm. 2021;354:2000237. doi: 10.1002/ardp.202000237.", "ArticleIdList": ["10.1002/ardp.202000237", "33226150"]}, {"Citation": "Jo S., Kim T., Iyer V.G., Im W. CHARMM-GUI: A web-based graphical user interface for CHARMM. J. Comput. Chem. 2008;29:1859\u20131865. doi: 10.1002/jcc.20945.", "ArticleIdList": ["10.1002/jcc.20945", "18351591"]}, {"Citation": "Brooks B.R., Brooks C.L., III, Mackerell A.D., Jr., Nilsson L., Petrella R.J., Roux B., Won Y., Archontis G., Bartels C., Boresch S., et al. CHARMM: The biomolecular simulation program. J. Comput. Chem. 2009;30:1545\u20131614. doi: 10.1002/jcc.21287.", "ArticleIdList": ["10.1002/jcc.21287", "PMC2810661", "19444816"]}, {"Citation": "Lee J., Cheng X., Swails J.M., Yeom M.S., Eastman P.K., Lemkul J.A., Wei S., Buckner J., Jeong J.C., Qi Y., et al. CHARMM-GUI Input Generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM Simulations Using the CHARMM36 Additive Force Field. J. Chem. Theory Comput. 2016;12:405\u2013413. doi: 10.1021/acs.jctc.5b00935.", "ArticleIdList": ["10.1021/acs.jctc.5b00935", "PMC4712441", "26631602"]}, {"Citation": "Best R.B., Zhu X., Shim J., Lopes P.E., Mittal J., Feig M., Mackerell A.D., Jr. Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone phi, psi and side-chain chi(1) and chi(2) dihedral angles. J. Chem. Theory Comput. 2012;8:3257\u20133273. doi: 10.1021/ct300400x.", "ArticleIdList": ["10.1021/ct300400x", "PMC3549273", "23341755"]}, {"Citation": "Phillips J.C., Braun R., Wang W., Gumbart J., Tajkhorshid E., Villa E., Chipot C., Skeel R.D., Kale L., Schulten K. Scalable molecular dynamics with NAMD. J. Comput. Chem. 2005;26:1781\u20131802. doi: 10.1002/jcc.20289.", "ArticleIdList": ["10.1002/jcc.20289", "PMC2486339", "16222654"]}, {"Citation": "Wawer M., Peltason L., Weskamp N., Teckentrup A., Bajorath J. Structure\u2013activity relationship anatomy by network-like similarity graphs and local structure\u2013activity relationship indices. J. Med. Chem. 2008;51:6075\u20136084. doi: 10.1021/jm800867g.", "ArticleIdList": ["10.1021/jm800867g", "18798611"]}, {"Citation": "Farhadi F., Khameneh B., Iranshahi M., Iranshahy M. Antibacterial activity of flavonoids and their structure\u2013activity relationship: An update review. Phytother. Res. 2019;33:13\u201340. doi: 10.1002/ptr.6208.", "ArticleIdList": ["10.1002/ptr.6208", "30346068"]}, {"Citation": "Burke B.J. Developments in Molecular Shape Analysis to Establish Spatial Similarity among Flexible Molecules. University of Illinois at Chicago, Health Sciences Center; Chicago, IL, USA: 1993."}, {"Citation": "Willett P. Similarity-based virtual screening using 2D fingerprints. Drug Discov. Today. 2006;11:1046\u20131053. doi: 10.1016/j.drudis.2006.10.005.", "ArticleIdList": ["10.1016/j.drudis.2006.10.005", "17129822"]}, {"Citation": "Briem H., Kuntz I.D. Molecular similarity based on DOCK-generated fingerprints. J. Med. Chem. 1996;39:3401\u20133408. doi: 10.1021/jm950800y.", "ArticleIdList": ["10.1021/jm950800y", "8765524"]}, {"Citation": "Willett P. Similarity searching using 2D structural fingerprints. Chemoinform. Comput. Chem. Biol. 2010;672:133\u2013158.", "ArticleIdList": ["20838967"]}, {"Citation": "Spackman M.A., McKinnon J.J. Fingerprinting intermolecular interactions in molecular crystals. CrystEngComm. 2002;4:378\u2013392. doi: 10.1039/B203191B.", "ArticleIdList": ["10.1039/B203191B"]}, {"Citation": "Chu H., He Q.-X., Wang J., Hu Y., Wang Y.-Q., Lin Z.-H. In silico design of novel benzohydroxamate-based compounds as inhibitors of histone deacetylase 6 based on 3D-QSAR, molecular docking, and molecular dynamics simulations. New J. Chem. 2020;44:21201\u201321210. doi: 10.1039/D0NJ04704J.", "ArticleIdList": ["10.1039/D0NJ04704J"]}, {"Citation": "Ieritano C., Campbell J.L., Hopkins W.S. Predicting differential ion mobility behaviour in silico using machine learning. Analyst. 2021;146:4737\u20134743. doi: 10.1039/D1AN00557J.", "ArticleIdList": ["10.1039/D1AN00557J", "34212943"]}, {"Citation": "Taha M., Ismail N.H., Ali M., Rashid U., Imran S., Uddin N., Khan K.M. Molecular hybridization conceded exceptionally potent quinolinyl-oxadiazole hybrids through phenyl linked thiosemicarbazide antileishmanial scaffolds: In silico validation and SAR studies. Bioorg. Chem. 2017;71:192\u2013200. doi: 10.1016/j.bioorg.2017.02.005.", "ArticleIdList": ["10.1016/j.bioorg.2017.02.005", "28228228"]}, {"Citation": "Heikamp K., Bajorath J. How do 2D fingerprints detect structurally diverse active compounds? Revealing compound subset-specific fingerprint features through systematic selection. J. Chem. Inf. Model. 2011;51:2254\u20132265. doi: 10.1021/ci200275m.", "ArticleIdList": ["10.1021/ci200275m", "21793563"]}, {"Citation": "Opo F.A.D.M., Rahman M.M., Ahammad F., Ahmed I., Bhuiyan M.A., Asiri A.M. Structure based pharmacophore modeling, virtual screening, molecular docking and ADMET approaches for identification of natural anti-cancer agents targeting XIAP protein. Sci. Rep. 2021;11:4049. doi: 10.1038/s41598-021-83626-x.", "ArticleIdList": ["10.1038/s41598-021-83626-x", "PMC7892887", "33603068"]}, {"Citation": "Duan J., Dixon S.L., Lowrie J.F., Sherman W. Analysis and comparison of 2D fingerprints: Insights into database screening performance using eight fingerprint methods. J. Mol. Graph. Model. 2010;29:157\u2013170. doi: 10.1016/j.jmgm.2010.05.008.", "ArticleIdList": ["10.1016/j.jmgm.2010.05.008", "20579912"]}, {"Citation": "Sastry M., Lowrie J.F., Dixon S.L., Sherman W. Large-scale systematic analysis of 2D fingerprint methods and parameters to improve virtual screening enrichments. J. Chem. Inf. Model. 2010;50:771\u2013784. doi: 10.1021/ci100062n.", "ArticleIdList": ["10.1021/ci100062n", "20450209"]}, {"Citation": "Kogej T., Engkvist O., Blomberg N., Muresan S. Multifingerprint based similarity searches for targeted class compound selection. J. Chem. Inf. Model. 2006;46:1201\u20131213. doi: 10.1021/ci0504723.", "ArticleIdList": ["10.1021/ci0504723", "16711740"]}, {"Citation": "Maggiora G., Vogt M., Stumpfe D., Bajorath J. Molecular similarity in medicinal chemistry: Miniperspective. J. Med. Chem. 2014;57:3186\u20133204. doi: 10.1021/jm401411z.", "ArticleIdList": ["10.1021/jm401411z", "24151987"]}, {"Citation": "Muegge I., Mukherjee P. An overview of molecular fingerprint similarity search in virtual screening. Expert Opin. Drug Discov. 2016;11:137\u2013148. doi: 10.1517/17460441.2016.1117070.", "ArticleIdList": ["10.1517/17460441.2016.1117070", "26558489"]}, {"Citation": "Turchi M., Cai Q., Lian G. An evaluation of in-silico methods for predicting solute partition in multiphase complex fluids\u2014A case study of octanol/water partition coefficient. Chem. Eng. Sci. 2019;197:150\u2013158. doi: 10.1016/j.ces.2018.12.003.", "ArticleIdList": ["10.1016/j.ces.2018.12.003"]}, {"Citation": "Sullivan K.M., Enoch S.J., Ezendam J., Sewald K., Roggen E.L., Cochrane S. An adverse outcome pathway for sensitization of the respiratory tract by low-molecular-weight chemicals: Building evidence to support the utility of in vitro and in silico methods in a regulatory context. Appl. Vitr. Toxicol. 2017;3:213\u2013226. doi: 10.1089/aivt.2017.0010.", "ArticleIdList": ["10.1089/aivt.2017.0010"]}, {"Citation": "Altamash T., Amhamed A., Aparicio S., Atilhan M. Effect of hydrogen bond donors and acceptors on CO2 absorption by deep eutectic solvents. Processes. 2020;8:1533. doi: 10.3390/pr8121533.", "ArticleIdList": ["10.3390/pr8121533"]}, {"Citation": "Wan Y., Tian Y., Wang W., Gu S., Ju X., Liu G. In silico studies of diarylpyridine derivatives as novel HIV-1 NNRTIs using docking-based 3D-QSAR, molecular dynamics, and pharmacophore modeling approaches. RSC Adv. 2018;8:40529\u201340543. doi: 10.1039/C8RA06475J.", "ArticleIdList": ["10.1039/C8RA06475J", "PMC9091378", "35557880"]}, {"Citation": "Escamilla-Guti\u00e9rrez A., Ribas-Aparicio R.M., C\u00f3rdova-Espinoza M.G., Castel\u00e1n-Vega J.A. In silico strategies for modeling RNA aptamers and predicting binding sites of their molecular targets. Nucleosides Nucleotides Nucleic Acids. 2021;40:798\u2013807. doi: 10.1080/15257770.2021.1951754.", "ArticleIdList": ["10.1080/15257770.2021.1951754", "34323642"]}, {"Citation": "Kaushik A.C., Kumar A., Bharadwaj S., Chaudhary R., Sahi S. Bioinformatics Techniques for Drug Discovery. Springer; Berlin/Heidelberg, Germany: 2018. Ligand-Based Approach for In-silico Drug Designing; pp. 11\u201319."}, {"Citation": "Jain A.N. Morphological similarity: A 3D molecular similarity method correlated with protein-ligand recognition. J. Comput.-Aided Mol. Des. 2000;14:199\u2013213. doi: 10.1023/A:1008100132405.", "ArticleIdList": ["10.1023/A:1008100132405", "10721506"]}, {"Citation": "Zhang H., Ren J.-X., Ma J.-X., Ding L. Development of an in silico prediction model for chemical-induced urinary tract toxicity by using na\u00efve Bayes classifier. Mol. Divers. 2019;23:381\u2013392. doi: 10.1007/s11030-018-9882-8.", "ArticleIdList": ["10.1007/s11030-018-9882-8", "30294757"]}, {"Citation": "Norinder U., Bergstr\u00f6m C.A. Prediction of ADMET properties. ChemMedChem Chem. Enabling Drug Discov. 2006;1:920\u2013937.", "ArticleIdList": ["16952133"]}, {"Citation": "Ferreira L.L., Andricopulo A.D. ADMET modeling approaches in drug discovery. Drug Discov. Today. 2019;24:1157\u20131165. doi: 10.1016/j.drudis.2019.03.015.", "ArticleIdList": ["10.1016/j.drudis.2019.03.015", "30890362"]}, {"Citation": "Idakwo G., Luttrell J., Chen M., Hong H., Zhou Z., Gong P., Zhang C. A review on machine learning methods for in silico toxicity prediction. J. Environ. Sci. Health Part C. 2018;36:169\u2013191. doi: 10.1080/10590501.2018.1537118.", "ArticleIdList": ["10.1080/10590501.2018.1537118", "30628866"]}, {"Citation": "Raies A.B., Bajic V.B. In silico toxicology: Computational methods for the prediction of chemical toxicity. Wiley Interdiscip. Rev. Comput. Mol. Sci. 2016;6:147\u2013172. doi: 10.1002/wcms.1240.", "ArticleIdList": ["10.1002/wcms.1240", "PMC4785608", "27066112"]}, {"Citation": "Xia X., Maliski E.G., Gallant P., Rogers D. Classification of kinase inhibitors using a Bayesian model. J. Med. Chem. 2004;47:4463\u20134470. doi: 10.1021/jm0303195.", "ArticleIdList": ["10.1021/jm0303195", "15317458"]}, {"Citation": "BIOVIA QSAR, ADMET and Predictive Toxicology.  [(accessed on 18 August 2022)].  Available online:  https://www.3dsbiovia.com/products/collaborative-science/biovia-discovery-studio/qsar-admet-and-predictive-toxicology.html."}, {"Citation": "Venkatapathy R., Wang N.C.Y., Martin T.M., Harten P.F., Young D. Structure\u2013Activity Relationships for Carcinogenic Potential. Gen. Appl. Syst. Toxicol. 2009 doi: 10.1002/9780470744307.gat079.", "ArticleIdList": ["10.1002/9780470744307.gat079"]}, {"Citation": "Goodrnan G., Wilson R. Comparison of the dependence of the TD50 on maximum tolerated dose for mutagens and nonmutagens. Risk Anal. 1992;12:525\u2013533. doi: 10.1111/j.1539-6924.1992.tb00709.x.", "ArticleIdList": ["10.1111/j.1539-6924.1992.tb00709.x", "1480798"]}, {"Citation": "Council N.R. Issues in Risk Assessment. National Academies Press (US); Washington, DC, USA: 1993. Correlation Between Carcinogenic Potency and the Maximum Tolerated Dose: Implications for Risk Assessment."}, {"Citation": "Gonella Diaza R., Manganelli S., Esposito A., Roncaglioni A., Manganaro A., Benfenati E. Comparison of in silico tools for evaluating rat oral acute toxicity. SAR QSAR Environ. Res. 2015;26:1\u201327. doi: 10.1080/1062936X.2014.977819.", "ArticleIdList": ["10.1080/1062936X.2014.977819", "25567032"]}, {"Citation": "Pizzo F., Benfenati E. In Silico Methods for Predicting Drug Toxicity. Springer; Berlin/Heidelberg, Germany: 2016. In silico models for repeated-dose toxicity (RDT): Prediction of the no observed adverse effect level (NOAEL) and lowest observed adverse effect level (LOAEL) for drugs; pp. 163\u2013176.", "ArticleIdList": ["27311467"]}, {"Citation": "Venkatapathy R., Moudgal C.J., Bruce R.M. Assessment of the oral rat chronic lowest observed adverse effect level model in TOPKAT, a QSAR software package for toxicity prediction. J. Chem. Inf. Comput. Sci. 2004;44:1623\u20131629. doi: 10.1021/ci049903s.", "ArticleIdList": ["10.1021/ci049903s", "15446819"]}, {"Citation": "Wilhelmus K.R. The Draize eye test. Surv. Ophthalmol. 2001;45:493\u2013515. doi: 10.1016/S0039-6257(01)00211-9.", "ArticleIdList": ["10.1016/S0039-6257(01)00211-9", "11425356"]}, {"Citation": "Pillay C.C., J\u00e4ger A.K., Mulholland D.A., Van Staden J. Cyclooxygenase inhibiting and anti-bacterial activities of South African Erythrina species. J. Ethnopharmacol. 2001;74:231\u2013237. doi: 10.1016/S0378-8741(00)00366-4.", "ArticleIdList": ["10.1016/S0378-8741(00)00366-4", "11274823"]}, {"Citation": "Oyama S.D.O., Souza L.A.D., Baldoqui D.C., Sarragiotto M.H., Silva A.A. Prenylated flavonoids from Maclura tinctoria fruits. Qu\u00edmica Nova. 2013;36:800\u2013802. doi: 10.1590/S0100-40422013000600010.", "ArticleIdList": ["10.1590/S0100-40422013000600010"]}, {"Citation": "Delle Monache G., De Rosa M.C., Scurria R., Vitali A., Cuteri A., Monacelli B., Pasqua G., Botta B. Comparison between metabolite productions in cell culture and in whole plant of Maclura pomifera. Phytochemistry. 1995;39:575\u2013580. doi: 10.1016/0031-9422(94)00971-U.", "ArticleIdList": ["10.1016/0031-9422(94)00971-U", "19830921"]}, {"Citation": "Atta-ur-Rahman . Studies in Natural Products Chemistry: Indices Part A. Elsevier Science; Amsterdam, The Netherlands: 1997."}, {"Citation": "Akhtar A., Hussain W., Rasool N. Probing the pharmacological binding properties, and reactivity of selective phytochemicals as potential HIV-1 protease inhibitors. Univ. Sci. 2019;24:441\u2013464. doi: 10.11144/Javeriana.SC24-3.artf.", "ArticleIdList": ["10.11144/Javeriana.SC24-3.artf"]}, {"Citation": "Sousa S.F., Fernandes P.A., Ramos M.J. Protein\u2013ligand docking: Current status and future challenges. Proteins Struct. Funct. Bioinform. 2006;65:15\u201326. doi: 10.1002/prot.21082.", "ArticleIdList": ["10.1002/prot.21082", "16862531"]}, {"Citation": "Hollingsworth S.A., Dror R.O. Molecular dynamics simulation for all. Neuron. 2018;99:1129\u20131143. doi: 10.1016/j.neuron.2018.08.011.", "ArticleIdList": ["10.1016/j.neuron.2018.08.011", "PMC6209097", "30236283"]}, {"Citation": "Liu X., Shi D., Zhou S., Liu H., Liu H., Yao X. Molecular dynamics simulations and novel drug discovery. Expert Opin. Drug Discov. 2018;13:23\u201337. doi: 10.1080/17460441.2018.1403419.", "ArticleIdList": ["10.1080/17460441.2018.1403419", "29139324"]}, {"Citation": "Hansson T., Oostenbrink C., van Gunsteren W. Molecular dynamics simulations. Curr. Opin. Struct. Biol. 2002;12:190\u2013196. doi: 10.1016/S0959-440X(02)00308-1.", "ArticleIdList": ["10.1016/S0959-440X(02)00308-1", "11959496"]}, {"Citation": "Kuzmanic A., Zagrovic B. Determination of ensemble-average pairwise root mean-square deviation from experimental B-factors. Biophys. J. 2010;98:861\u2013871. doi: 10.1016/j.bpj.2009.11.011.", "ArticleIdList": ["10.1016/j.bpj.2009.11.011", "PMC2830444", "20197040"]}, {"Citation": "Liu P., Lu J., Yu H., Ren N., Lockwood F.E., Wang Q.J. Lubricant shear thinning behavior correlated with variation of radius of gyration via molecular dynamics simulations. J. Chem. Phys. 2017;147:084904. doi: 10.1063/1.4986552.", "ArticleIdList": ["10.1063/1.4986552", "28863549"]}, {"Citation": "Kumar K., Anbarasu A., Ramaiah S. Molecular docking and molecular dynamics studies on \u03b2-lactamases and penicillin binding proteins. Mol. Biosyst. 2014;10:891\u2013900. doi: 10.1039/C3MB70537D.", "ArticleIdList": ["10.1039/C3MB70537D", "24503740"]}, {"Citation": "Mitternacht S. FreeSASA: An open source C library for solvent accessible surface area calculations. F1000Research. 2016;5:189. doi: 10.12688/f1000research.7931.1.", "ArticleIdList": ["10.12688/f1000research.7931.1", "PMC4776673", "26973785"]}, {"Citation": "Naik V.R., Munikumar M., Ramakrishna U., Srujana M., Goudar G., Naresh P., Kumar B.N., Hemalatha R.J. Dynamics, Remdesivir (GS-5734) as a therapeutic option of 2019-nCOV main protease\u2013in silico approach. J. Biomol. Struct. Dyn. 2021;39:4701\u20134714. doi: 10.1080/07391102.2020.1781694.", "ArticleIdList": ["10.1080/07391102.2020.1781694", "PMC7332877", "32568620"]}, {"Citation": "Magro P., Zanella I., Pescarolo M., Castelli F., Quiros-Roldan E.J.B.J. Lopinavir/ritonavir: Repurposing an old drug for HIV infection in COVID-19 treatment. Biomed. J. 2021;44:43\u201353. doi: 10.1016/j.bj.2020.11.005.", "ArticleIdList": ["10.1016/j.bj.2020.11.005", "PMC7654234", "33608241"]}, {"Citation": "Alexpandi R., De Mesquita J.F., Pandian S.K., Ravi A.V. Quinolines-based SARS-CoV-2 3CLpro and RdRp inhibitors and Spike-RBD-ACE2 inhibitor for drug-repurposing against COVID-19: An in silico analysis. Front. Microbiol. 2020;11:1796. doi: 10.3389/fmicb.2020.01796.", "ArticleIdList": ["10.3389/fmicb.2020.01796", "PMC7390959", "32793181"]}, {"Citation": "Elmezayen A.D., Al-Obaidi A., \u015eahin A.T., Yelek\u00e7i K. Dynamics, Drug repurposing for coronavirus (COVID-19): In silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes. J. Biomol. Struct. Dyn. 2021;39:2980\u20132992. doi: 10.1080/07391102.2020.1758791.", "ArticleIdList": ["10.1080/07391102.2020.1758791", "PMC7189413", "32306862"]}, {"Citation": "Keretsu S., Bhujbal S.P., Cho S.J. Rational approach toward COVID-19 main protease inhibitors via molecular docking, molecular dynamics simulation and free energy calculation. Sci. Rep. 2020;10:17716. doi: 10.1038/s41598-020-74468-0.", "ArticleIdList": ["10.1038/s41598-020-74468-0", "PMC7572583", "33077821"]}, {"Citation": "Koulgi S., Jani V., Uppuladinne M., Sonavane U., Nath A.K., Darbari H., Joshi R. Dynamics, Drug repurposing studies targeting SARS-CoV-2: An ensemble docking approach on drug target 3C-like protease (3CLpro) J. Biomol. Struct. Dyn. 2021;39:5735\u20135755. doi: 10.1080/07391102.2020.1792344.", "ArticleIdList": ["10.1080/07391102.2020.1792344", "PMC7441806", "32679006"]}, {"Citation": "Eissa I.H., Khalifa M.M., Elkaeed E.B., Hafez E.E., Alsfouk A.A., Metwaly A.M. In Silico Exploration of Potential Natural Inhibitors against SARS-Cov-2 nsp10. Molecules. 2021;26:6151. doi: 10.3390/molecules26206151.", "ArticleIdList": ["10.3390/molecules26206151", "PMC8539059", "34684735"]}, {"Citation": "Elkaeed E.B., Youssef F.S., Eissa I.H., Elkady H., Alsfouk A.A., Ashour M.L., El Hassab M.A., Abou-Seri S.M., Metwaly A.M. Multi-Step In Silico Discovery of Natural Drugs against COVID-19 Targeting Main Protease. Int. J. Mol. Sci. 2022;23:6912. doi: 10.3390/ijms23136912.", "ArticleIdList": ["10.3390/ijms23136912", "PMC9266348", "35805916"]}, {"Citation": "Elkaeed E.B., Eissa I.H., Elkady H., Abdelalim A., Alqaisi A.M., Alsfouk A.A., Elwan A., Metwaly A.M. A Multistage In Silico Study of Natural Potential Inhibitors Targeting SARS-CoV-2 Main Protease. Int. J. Mol. Sci. 2022;23:8407. doi: 10.3390/ijms23158407.", "ArticleIdList": ["10.3390/ijms23158407", "PMC9369012", "35955547"]}, {"Citation": "Elkaeed E.B., Metwaly A.M., Alesawy M.S., Saleh A.M., Alsfouk A.A., Eissa I.H. Discovery of Potential SARS-CoV-2 Papain-like Protease Natural Inhibitors Employing a Multi-Phase In Silico Approach. Life. 2022;12:1407. doi: 10.3390/life12091407.", "ArticleIdList": ["10.3390/life12091407", "PMC9505301", "36143445"]}, {"Citation": "Eissa I.H., Alesawy M.S., Saleh A.M., Elkaeed E.B., Alsfouk B.A., El-Attar A.-A.M.M., Metwaly A.M. Ligand and Structure-Based In Silico Determination of the Most Promising SARS-CoV-2 nsp16-nsp10 2&prime;-o-Methyltransferase Complex Inhibitors among 3009 FDA Approved Drugs. Molecules. 2022;27:2287.", "ArticleIdList": ["PMC9000629", "35408684"]}, {"Citation": "Elkaeed E.B., Elkady H., Belal A., Alsfouk B.A., Ibrahim T.H., Abdelmoaty M., Arafa R.K., Metwaly A.M., Eissa I.H. Multi-Phase In Silico Discovery of Potential SARS-CoV-2 RNA-Dependent RNA Polymerase Inhibitors among 3009 Clinical and FDA-Approved Related Drugs. Processes. 2022;10:530. doi: 10.3390/pr10030530.", "ArticleIdList": ["10.3390/pr10030530"]}, {"Citation": "Metwaly A.M., Elwan A., El-Attar A.-A.M.M., Al-Rashood S.T., Eissa I.H. Structure-Based Virtual Screening, Docking, ADMET, Molecular Dynamics, and MM-PBSA Calculations for the Discovery of Potential Natural SARS-CoV-2 Helicase Inhibitors from the Traditional Chinese Medicine. J. Chem. 2022;2022:7270094. doi: 10.1155/2022/7270094.", "ArticleIdList": ["10.1155/2022/7270094"]}, {"Citation": "Alesawy M.S., Elkaeed E.B., Alsfouk A.A., Metwaly A.M., Eissa I. In Silico Screening of Semi-Synthesized Compounds as Potential Inhibitors for SARS-CoV-2 Papain-Like Protease: Pharmacophoric Features, Molecular Docking, ADMET, Toxicity and DFT Studies. Molecules. 2021;26:6593. doi: 10.3390/molecules26216593.", "ArticleIdList": ["10.3390/molecules26216593", "PMC8588135", "34771004"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "11", "Day": "3"}, {"Year": "2022", "Month": "11", "Day": "14"}, {"Year": "2022", "Month": "11", "Day": "15"}, {"Year": "2022", "Month": "11", "Day": "24", "Hour": "10", "Minute": "43"}, {"Year": "2022", "Month": "11", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "11", "Day": "25", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "11", "Day": "16"}], "PublicationStatus": "epublish", "ArticleIdList": ["36422263", "PMC9693093", "10.3390/metabo12111122", "metabo12111122"]}}], "PubmedBookArticle": []}